Profitability Metrics

Gross Margin
28.07%
Operating Margin
19.99%
Net Margin
16.41%

Efficiency Metrics

Revenue per Expense Ratio
1.25
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
35.78%
Income Tax Rate
2.79%
EPS
1.1900000000

Balance Sheet Analysis

Current Ratio
2.26
Cash Ratio
1.48
Working Capital
$176.68M
Debt to Equity
0.78
Debt to Assets
39.85%
Equity Ratio
51.01%

Cash Flow Analysis

Operating Cash Flow Ratio
28.23%
Free Cash Flow Ratio
20.53%
CapEx to Revenue
7.70%
Dividends Paid
$169.99M
Stock Buybacks
$4.30M
Total Shareholder Returns
$174.29M
Cash Position Change
81.79%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased dividend payments by 1.31%

Detailed Growth Metrics

Core Performance

Revenue
16.26%
Net Income
62.03%
EPS
63.01%
Operating Income
27.43%

Operational Efficiency

R&D Expenses
-100.00%
SG&A Expenses
18.73%
Operating Cash Flow
10.84%
Free Cash Flow
176.81%

Balance Sheet Health

Assets
-3.74%
Debt
-9.36%
Book Value per Share
-2.60%
Inventory
30.71%

Shareholder Returns

Dividends per Share
1.31%
Shares Outstanding
1.26%

Long Term Trends

3Y Revenue/Share
11.23%
5Y Revenue/Share
12.89%
3Y Dividend/Share
5.03%
5Y Dividend/Share
8.31%